IPO registrations (S-1, F-1) · Registrants
SteadyMed Ltd.
- SEC CIK
- 1619087 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2015-02-06, last 2015-03-16; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2015-03-20; declared effective 2015-03-19
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- L3
- Business address
- 5 OPPENHEIMER STREET, Rehovot, L3 76701
- EDGAR entity type
- operating
- Insiders and CEO pay
- SteadyMed Ltd. on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2015-03-09)
- Final price
- $8.50 per share, below the range (424B4 filed 2015-03-20, an initial public offering)
- Shares sold
- 4,700,000
- Gross proceeds
- $39,950,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol STDY
- Lead underwriters
- Wells Fargo
- Syndicate
- RBC Capital Markets; JMP Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: SteadyMed Ltd. EXACT (CIK (EXACT))
- SEC filer: SteadyMed Ltd. EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-02-06 | S-1 | S-1 (registration) | SteadyMed Ltd. | 0001047469-15-000653 ↗ |
| 2015-03-09 | S-1/A | S-1/A (amendment) | SteadyMed Ltd. | 0001047469-15-001844 ↗ |
| 2015-03-16 | S-1/A | S-1/A (amendment) | SteadyMed Ltd. | 0001104659-15-020149 ↗ |
| 2015-03-19 | S-1MEF | S-1MEF (added securities) | SteadyMed Ltd. | 0001104659-15-021165 ↗ |
| 2015-03-19 | EFFECT | EFFECT (declared effective) | SteadyMed Ltd. | 9999999995-15-000645 ↗ |
| 2015-03-20 | 424B4 | 424B4 (final prospectus) | SteadyMed Ltd. | 0001047469-15-002522 ↗ |
| 2016-09-21 | EFFECT | EFFECT (declared effective) | SteadyMed Ltd. | 9999999995-16-005739 ↗ |
| 2016-12-20 | EFFECT | EFFECT (declared effective) | SteadyMed Ltd. | 9999999995-16-006513 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-09 | S-1/A | registration statement | $12.00–$14.00 | 4,250,000 | - | Nasdaq STDY | 3 | primary document; range, shares headline, cover names 3 | document ↗ | |
| 2015-03-16 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2015-03-20 | 424B4 | final prospectus | $8.50 | 4,700,000 | $39,950,000 | Nasdaq STDY | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bank Keith | Director,TenPercentOwner | 7 | 2015–2018 | ||
| DEERFIELD MANAGEMENT CO | TenPercentOwnerOther | 2 | 2015 | ||
| Deerfield Mgmt III, L.P. | TenPercentOwnerOther | 2 | 2015 | ||
| Deerfield Mgmt L.P. | TenPercentOwnerOther | 2 | 2015 | ||
| Deerfield Private Design Fund III, L.P. | TenPercentOwnerOther | 2 | 2015 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwnerOther | 2 | 2015 | ||
| FARR STEPHEN J | Director | 5 | 2015–2018 | ||
| Flynn James E | TenPercentOwnerOther | 2 | 2015 | person page Fuzzy | |
| Ginor Ron | Director | 9 | 2015–2018 | ||
| Huffman Donald D | Director | 5 | 2015–2018 | ||
| Nassif David W. | Officer | Chief Financial Officer; EVP and CFO | 7 | 2015–2018 | |
| Noymer Peter D. | Officer | EVP and COO; EVP and CTO; See Remarks | 3 | 2015–2016 | |
| RIGBY JONATHAN | Director,Officer | President and CEO; See Remarks | 8 | 2015–2018 | |
| STARK BRIAN JAY | Director,TenPercentOwner | 10 | 2015–2018 | ||
| SteadyMed Investors, LLC | TenPercentOwner | 4 | 2015–2018 | ||
| Cermak Elizabeth | Director | 5 | 2015–2018 | ||
| ISALY SAMUEL D | TenPercentOwner | 2 | 2016–2017 | ||
| OrbiMed Advisors Israel II Ltd | TenPercentOwner | 3 | 2016–2018 | ||
| ORBIMED ADVISORS LLC | TenPercentOwner | 3 | 2016–2018 | ||
| OrbiMed Capital GP VI LLC | TenPercentOwner | 3 | 2016–2018 | ||
| OrbiMed Israel GP II, L.P. | TenPercentOwner | 3 | 2016–2018 | ||
| UNITED THERAPEUTICS Corp | TenPercentOwner | 1 | 2018 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2017-05-08 | SteadyMed Ltd. | Pharmaceuticals | $30,000,617 | $30,000,617 | 19 | 1 |
| 2016-08-17 | SteadyMed Ltd. | Pharmaceuticals | $32,000,000 | $21,333,322 | 13 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | SteadyMed Ltd. | Form D private offerings | CIK (EXACT) | |
| IPO registrant | G Medical Innovations Holdings Ltd. | IPO registrations (S-1, F-1) | same street address and ZIP code, 5 OPPENHEIMER ST 76701 (FUZZY: a shared address, not proof of a shared organization) | |
| SEC filer | SteadyMed Ltd. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.